Annemiek Voorzee

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostics and life sciences industries. The Company’s xMAP® multiplex solutions include an open architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company’s xMAP technology is sold worldwide and is already is use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporations or xMAP can be obtained at www.luminexcorp.com

xTAG Technology from Luminex

xMAP Technology

Luminex Corporation develops, manufactures and markets proprietary technologies and assays for biological testing based on its unique
bead-based multiplexing platforms. This approach is unmatched in performance and flexibility. It enables Luminex and its partners to design,
develop and deliver tests for a full spectrum of life science requirements. Not only can xMAP Technology be used for proteomic, genomic and
epigenetic assays, it also allows creation of flexible panels to meet the needs of clinicians and life science researchers alike. There is a huge
demand for Luminex focused multiplexing technology. In diagnostics there is a need to combine individual tests with flexible panels and in genetic
testing there is a need for more focused markers.

Benefits of Luminex Technology

Luminex uses an approach that aims at delivering their unique
technologies to the people that need them – as quickly as possible.
We work with a channel-partner model, in which we share our
resources openly with strategic partners. This enables our partners,
who are market leaders in their respective fields, to develop and
market their own systems and applications using xMAP® Technology.
Our approach is supported by our open-architecture technology,
which creates significant opportunities for our end-users. By pooling
our efforts to develop assays, hardware, and software, we are creating
multiple channels for success, while speeding the adoption of xMAP
Technology in a broad range of applications.
Saving Lives Faster with Partners
Luminex partners draw upon their specific expertise to create
their own multiplexed kits based on our xMAP Technology. Partners can
develop custom software for the xMAP platform according to individual
market needs. Luminex can even connect ass

Annemiek Voorzee

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.